Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Phase I Study With Sorafenib in Addition to Vinflunine in Progressive Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract

NCT01844947 is registered in ClinicalTrials.gov with Dr Anders Ullén as lead sponsor.

NCT NCT01844947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01844947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Phase I Study With Sorafenib in Addition to Vinflunine in Progressive Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract
Lead sponsor
Dr Anders Ullén
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2012
Completion date
June 5, 2018
Enrollment
22 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, renal pelvis cancer, ureter cancer, urethra cancer, urothelial carcinoma